Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Summary

Current therapies for Stage IV bladder cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV bladder cancer PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV bladder cancer.

Timeline

Start

1996-05-06

Primary completion

1998-05-04

Completion

1998-05-04

Drugs

Indications